FCPM III SERVICES B.V. Long-Term Concentrated

CIK: 0002013410 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $500,389 (100.0% shares, 0.0% debt)

Holdings (9)

NAMS NEWAMSTERDAM PHARMA COMPANY 52.4%

Value ($000) $262,000 Shares 9,212,384 Est. Cost $9.56 Unrealized +150.6%

DYN DYNE THERAPEUTICS INC 13.8%

Value ($000) $69,105 Shares 5,462,846 Est. Cost $12.58 Unrealized -9.3%

ENGN ENGENE HOLDINGS INC 13.1%

Value ($000) $65,790 Shares 9,632,561 Est. Cost $10.14 Unrealized -55.0%

— ASTRIA THERAPEUTICS INC 6.0%

Value ($000) $29,903 Shares 4,107,537 Est. Cost $7.88 Unrealized —

BCYC BICYCLE THERAPEUTICS PLC 5.3%

Value ($000) $26,721 Shares 3,452,330 Est. Cost $18.38 Unrealized —

VOR VOR BIOPHARMA INC 3.7%

Value ($000) $18,496 Shares 379,640 Est. Cost $40.21 Unrealized 0.0%

REPL REPLIMUNE GROUP INC 3.5%

Value ($000) $17,424 Shares 4,158,368 Est. Cost $11.28 Unrealized -43.4%

RAPT RAPT THERAPEUTICS INC 1.8%

Value ($000) $8,878 Shares 344,237 Est. Cost $7.63 Unrealized +71.5%

ENGNW ENGENE HOLDINGS INC 0.4%

Value ($000) $2,072 Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	9,212,384	$262,000	52.4%	$9.56	+150.6%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	5,462,846	$69,105	13.8%	$12.58	-9.3%	COM	26818M108
ENGN	ENGENE HOLDINGS INC	9,632,561	$65,790	13.1%	$10.14	-55.0%	COM	29286M105
—	ASTRIA THERAPEUTICS INC	4,107,537	$29,903	6.0%	$7.88	—	COM	04635X102
BCYC	BICYCLE THERAPEUTICS PLC	3,452,330	$26,721	5.3%	$18.38	—	SPONSORED ADS	088786108
VOR	VOR BIOPHARMA INC	379,640	$18,496	3.7%	$40.21	0.0%	COM NEW	929033207
REPL	REPLIMUNE GROUP INC	4,158,368	$17,424	3.5%	$11.28	-43.4%	COM	76029N106
RAPT	RAPT THERAPEUTICS INC	344,237	$8,878	1.8%	$7.63	+71.5%	COM NEW	75382E208
ENGNW	ENGENE HOLDINGS INC	2,878,148	$2,072	0.4%	$0.63	—	W EXP 10/31/2028	29286M113